Haleon Establishing Own Distribution In India To Unleash Growth
Executive Summary
Haleon is taking back full control of its interests in India by terminating a distribution deal for its OTC and oral care brands signed with Hindustan Unilever in 2020.
You may also be interested in...
Euro Q4 Consumer Health Earnings Preview: Sanofi, Bayer, Reckitt And Haleon
Major Europe-based consumer health players Sanofi Bayer, Reckitt and Haleon feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q4 2022 results over the coming weeks.
Haleon Raises Sales Guidance But Warns Of Tougher Q4
While Haleon expects 2022 sales to grow by around 8%, the UK-based consumer health giant faces a more difficult end to the year as it begins to cycle over significant price increases rolled out towards the end of 2021.
Bayer Leads Push For Self-Care In India As Local Business Launches
Bayer has launched a dedicated Consumer Health business in India to market products in key OTC categories. The company is also working to bring different stakeholders together through the creation of a new organization dedicated to promoting self-care in the South Asian country.